04/28/2025
6:30 AM | Citius Pharmaceuticals (Filer)
| Form DEF 14A | |
04/28/2025
6:32 AM | Citius Pharmaceuticals (Filer)
| Form DEFA14A | |
04/02/2025
6:27 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
03/10/2025
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/06/2025
8:20 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
3:05 PM | Citius Pharmaceuticals (Filer)
| Form DEF 14A | |
01/27/2025
3:07 PM | Citius Pharmaceuticals (Filer)
| Form DEFA14A | |
01/16/2025
3:30 PM | Citius Pharmaceuticals (Filer)
| Form PRE 14A | |
01/08/2025
3:05 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
8:00 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for CTXR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
01/07/2025
8:11 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
4:10 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
4:00 PM | Citius Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/20/2024
3:30 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:05 PM | Citius Pharmaceuticals (Subject)
Mazur Leonard L (Filed by)
| Form SC 13D/A | |
11/25/2024
4:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
7:30 AM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
MCGRATH DENNIS M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Dutia Suren G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Czuczman Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Bartushak Jaime (Reporting)
Citius Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Smith Robert Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
4:00 PM | Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
4:25 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:26 PM | Citius Pharmaceuticals (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
4:27 PM | Citius Pharmaceuticals (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
7:30 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
4:26 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:15 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Citius Pharmaceuticals (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:01 PM | Citius Pharmaceuticals (Issuer)
Holuka Eugene Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:34 PM | CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Pharmaceuticals (Filed by)
| Form SC 13D | |
08/16/2024
3:35 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
5:19 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:25 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Pharmaceuticals (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:10 PM | Citius Pharmaceuticals (Filer)
| Form 424B5 | |
Elon just did WHAT!? (Ad) As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC.
Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever.
But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs…
Paving the way for Elon Musk's secret master plan. Click here to see how to claim your stake before they launch to avoid missing out. |
08/12/2024
4:25 PM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
3:51 PM | Citius Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
8:20 AM | Citius Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
